CIK: 0001040508 · Show all filings
Period: Q3 2021 (← Previous) (Next →)
Filing Date: Nov 15, 2021
Total Value ($000): $8,479,874 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | DIVERSEY HLDGS LTD | 236,350,134 | $3,791,056 | 44.7% | $14.71 | — | ORD SHS | G28923103 |
| SGRY | SURGERY PARTNERS INC | 49,064,576 | $2,077,394 | 24.5% | $32.73 | +55.9% | COM | 86881A100 |
| — | CEREVEL THERAPEUTICS HLDNG, INC. | 60,632,356 | $1,788,655 | 21.1% | $16.58 | — | COM | 15678U128 |
| AVAH | AVEANNA HEALTHCARE HLDGS INC | 81,029,675 | $649,858 | 7.7% | $11.86 | -18.3% | COM | 05356F105 |
| IQV | IQVIA HLDGS INC | 617,484 | $147,912 | 1.7% | $101.80 | +147.9% | COM | 46266C105 |
| ADV | ADVANTAGE SOLUTIONS INC | 2,890,000 | $24,999 | 0.3% | $10.52 | -10.8% | COM CL A | 00791N102 |